View Future GrowthIBU-tec advanced materials 過去の業績過去 基準チェック /36IBU-tec advanced materialsの収益は年間平均-40.7%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間3.3% 3.7%割合で 増加しています。 IBU-tec advanced materialsの自己資本利益率は0.01%であり、純利益率は0.01%です。主要情報-40.72%収益成長率-41.05%EPS成長率Chemicals 業界の成長4.35%収益成長率3.71%株主資本利益率0.011%ネット・マージン0.013%次回の業績アップデート24 Aug 2026最近の業績更新Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €47.0m (down 10.0% from FY 2024). Net income: €5.7k (up €5.31m from FY 2024). Profit margin: 0% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 7.0% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026お知らせ • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025Reported Earnings • May 19Full year 2024 earnings releasedFull year 2024 results: Revenue: €54.1m (up 10% from FY 2023). Net loss: €5.31m (loss widened 113% from FY 2023). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.7% decline forecast for the Chemicals industry in the United Kingdom.すべての更新を表示Recent updatesUpcoming Dividend • May 13Upcoming dividend of €0.12 per shareEligible shareholders must have bought the stock before 20 May 2026. Payment date: 22 May 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 0.7%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (4.0%).お知らせ • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €47.0m (down 10.0% from FY 2024). Net income: €5.7k (up €5.31m from FY 2024). Profit margin: 0% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 7.0% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026New Risk • Mar 20New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €209k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Currently unprofitable and not forecast to become profitable over next 2 years (€209k net loss in 2 years). Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (€84.8m market cap, or US$98.2m).New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change).New Risk • Feb 11New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €82.4m (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Market cap is less than US$100m (€82.4m market cap, or US$97.9m).New Risk • Jan 01New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €1.3m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (27% average weekly change). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (€1.3m net loss in 2 years).お知らせ • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025Reported Earnings • May 19Full year 2024 earnings releasedFull year 2024 results: Revenue: €54.1m (up 10% from FY 2023). Net loss: €5.31m (loss widened 113% from FY 2023). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Apr 17IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time.お知らせ • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€28.3m market cap, or US$30.8m).お知らせ • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.7% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Aug 29IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024お知らせ • Mar 22IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024.Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improves as stock rises 35%After last week's 35% share price gain to €12.68, the stock trades at a trailing P/E ratio of 51.8x. Average trailing P/E is 20x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 61% over the past year.お知らせ • Mar 21IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024New Risk • Mar 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m).Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €9.99, the stock trades at a trailing P/E ratio of 41.5x. Average trailing P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 71% over the past year.Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €13.12, the stock trades at a trailing P/E ratio of 54.9x. Average trailing P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 60% over the past year.Valuation Update With 7 Day Price Move • Jan 15Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €13.22, the stock trades at a trailing P/E ratio of 48.1x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 63% over the past year.New Risk • Dec 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m).Valuation Update With 7 Day Price Move • Oct 23Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €18.54, the stock trades at a forward P/E ratio of 57x. Average forward P/E is 15x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 9.8% over the past year.New Risk • Oct 21New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €92.1m (US$97.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€92.1m market cap, or US$97.5m).Reported Earnings • Aug 30First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022)First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in the United Kingdom.New Risk • Aug 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio).収支内訳IBU-tec advanced materials の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史LSE:0UNS 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 2546015030 Sep 2546-115030 Jun 2546-315031 Mar 2549-415031 Dec 2452-515030 Sep 2451-615030 Jun 2449-615031 Mar 2449-414031 Dec 2349-214030 Sep 2350-114030 Jun 2350114031 Mar 2352114031 Dec 2254113030 Sep 2254113030 Jun 2254113031 Mar 2249112031 Dec 2145012030 Sep 2142-112030 Jun 2139-211031 Mar 2136012031 Dec 2033112030 Sep 2034112030 Jun 2035212031 Mar 2042112031 Dec 1949113030 Sep 1957213030 Jun 1951213031 Mar 1942212031 Dec 1833211030 Sep 181809030 Jun 1817-19031 Mar 181708031 Dec 171708030 Sep 171828030 Jun 171838031 Mar 171838031 Dec 161838031 Dec 1517370質の高い収益: 0UNSは 高品質の収益 を持っています。利益率の向上: 0UNS過去に利益を上げました。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 0UNS過去 5 年間で収益を上げており、収益は年間-40.7%増加しています。成長の加速: 0UNSは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。収益対業界: 0UNS昨年収益を上げたため、昨年の収益成長をChemicals業界 ( 1.2% ) と比較することは困難です。株主資本利益率高いROE: 0UNSの 自己資本利益率 ( 0.01% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/15 23:23終値2026/07/15 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋IBU-tec advanced materials AG 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Patrick SpeckMontega AGOliver SchwarzWarburg Research GmbH
Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €47.0m (down 10.0% from FY 2024). Net income: €5.7k (up €5.31m from FY 2024). Profit margin: 0% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 7.0% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026
お知らせ • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025
Reported Earnings • May 19Full year 2024 earnings releasedFull year 2024 results: Revenue: €54.1m (up 10% from FY 2023). Net loss: €5.31m (loss widened 113% from FY 2023). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025
Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.7% decline forecast for the Chemicals industry in the United Kingdom.
Upcoming Dividend • May 13Upcoming dividend of €0.12 per shareEligible shareholders must have bought the stock before 20 May 2026. Payment date: 22 May 2026. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 0.7%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (4.0%).
お知らせ • Apr 09+ 1 more updateIBU-tec advanced materials AG announces Annual dividend, payable on May 22, 2026IBU-tec advanced materials AG announced Annual dividend of EUR 0.1200 per share payable on May 22, 2026, ex-date on May 20, 2026 and record date on May 21, 2026.
Reported Earnings • Apr 08Full year 2025 earnings releasedFull year 2025 results: Revenue: €47.0m (down 10.0% from FY 2024). Net income: €5.7k (up €5.31m from FY 2024). Profit margin: 0% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 7.0% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Mar 30+ 1 more updateIBU-tec advanced materials AG to Report Fiscal Year 2025 Results on Apr 08, 2026IBU-tec advanced materials AG announced that they will report fiscal year 2025 results at 12:00 PM, Central European Standard Time on Apr 08, 2026
New Risk • Mar 20New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €209k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Currently unprofitable and not forecast to become profitable over next 2 years (€209k net loss in 2 years). Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (€84.8m market cap, or US$98.2m).
New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (10% average weekly change).
New Risk • Feb 11New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €82.4m (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.7% average weekly change). Market cap is less than US$100m (€82.4m market cap, or US$97.9m).
New Risk • Jan 01New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €2.8m Forecast net loss in 2 years: €1.3m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (27% average weekly change). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (€1.3m net loss in 2 years).
お知らせ • Jun 24IBU-tec advanced materials AG to Report First Half, 2025 Results on Aug 27, 2025IBU-tec advanced materials AG announced that they will report first half, 2025 results on Aug 27, 2025
Reported Earnings • May 19Full year 2024 earnings releasedFull year 2024 results: Revenue: €54.1m (up 10% from FY 2023). Net loss: €5.31m (loss widened 113% from FY 2023). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Apr 17IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025IBU-tec advanced materials AG, Annual General Meeting, May 26, 2025, at 10:00 W. Europe Standard Time.
お知らせ • Apr 16Ibu-Tec Advanced Materials Ag Provides Revenue Guidance for 2025Ibu-Tec Advanced Materials Ag provided Revenue Guidance for 2025. For the period, the company expected revenue EUR 43 million to EUR 45 million after consolidated revenues of around EUR 50.6 million in the past financial year according to preliminary unaudited figures.
New Risk • Mar 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€28.3m market cap, or US$30.8m).
お知らせ • Jan 08IBU-tec advanced materials AG to Report Fiscal Year 2024 Results on Mar 20, 2025IBU-tec advanced materials AG announced that they will report fiscal year 2024 results at 12:00 PM, Central European Standard Time on Mar 20, 2025
Reported Earnings • Sep 01First half 2024 earnings released: €0.66 loss per share (vs €0.078 profit in 1H 2023)First half 2024 results: €0.66 loss per share (down from €0.078 profit in 1H 2023). Revenue: €25.3m (down 1.1% from 1H 2023). Net loss: €3.15m (down €3.53m from profit in 1H 2023). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.7% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Aug 29IBU-tec advanced materials AG to Report First Half, 2024 Results on Aug 27, 2024IBU-tec advanced materials AG announced that they will report first half, 2024 results on Aug 27, 2024
お知らせ • Mar 22IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024IBU-tec advanced materials AG, Annual General Meeting, Apr 30, 2024.
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improves as stock rises 35%After last week's 35% share price gain to €12.68, the stock trades at a trailing P/E ratio of 51.8x. Average trailing P/E is 20x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 61% over the past year.
お知らせ • Mar 21IBU-tec advanced materials AG to Report Fiscal Year 2023 Results on Mar 21, 2024IBU-tec advanced materials AG announced that they will report fiscal year 2023 results on Mar 21, 2024
New Risk • Mar 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€47.5m market cap, or US$51.9m).
Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €9.99, the stock trades at a trailing P/E ratio of 41.5x. Average trailing P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 71% over the past year.
Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €13.12, the stock trades at a trailing P/E ratio of 54.9x. Average trailing P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 60% over the past year.
Valuation Update With 7 Day Price Move • Jan 15Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €13.22, the stock trades at a trailing P/E ratio of 48.1x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 63% over the past year.
New Risk • Dec 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €90.7m (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€90.7m market cap, or US$97.7m).
Valuation Update With 7 Day Price Move • Oct 23Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to €18.54, the stock trades at a forward P/E ratio of 57x. Average forward P/E is 15x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 9.8% over the past year.
New Risk • Oct 21New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: €92.1m (US$97.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio). Minor Risk Market cap is less than US$100m (€92.1m market cap, or US$97.5m).
Reported Earnings • Aug 30First half 2023 earnings released: EPS: €0.078 (vs €0.10 in 1H 2022)First half 2023 results: EPS: €0.078 (down from €0.10 in 1H 2022). Revenue: €25.5m (down 14% from 1H 2022). Net income: €372.8k (down 24% from 1H 2022). Profit margin: 1.5% (down from 1.7% in 1H 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 5.0% decline forecast for the Chemicals industry in the United Kingdom.
New Risk • Aug 28New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. High level of non-cash earnings (22% accrual ratio).